|
"We are taking a stand against an escalating threat [of Lyme disease in Canada], and we are doing so by taking a very powerful weapon to that table.. and that weapon is science."
"one of the unique things we offer in this lab is a clinical academic pipeline and that's what really sets us apart. What we are trying to develop here is this idea that we are going to be working with patients as stakeholders and collaborators in research and that we're studying the conditions that they find relevant..." "We don't want to do research that doesn't have clinical significance, we want to bring something to the clinic that will impact the health of Canadians." – Dr. Melanie Wills, PhD, Director, the G. Magnotta Lyme Disease Research Lab, University of Guelph |
lyme_benchmark_survey[1].pdf | |
File Size: | 273 kb |
File Type: |